Upstream Bio, Inc.
UPBNasdaqCIK 2022626HealthcareFiscal year ends Dec 31
Reports and events: 30 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0107:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-377485 |
| 2026-08-1107:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343417 |
| 2026-08-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343407 |
| 2026-06-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-265800 |
| 2026-05-1307:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-220584 |
| 2026-05-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220578 |
| 2026-04-1616:05 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001193125-26-158966 |
| 2026-03-2617:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-126572 |
| 2026-03-2616:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-126188 |
| 2026-03-2607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-125057 |
| 2026-02-1109:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-045649 |
| 2026-02-1106:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-045500 |
| 2025-11-0507:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-265713 |
| 2025-11-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265705 |
| 2025-09-0208:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002022626-25-000005 |
| 2025-08-0607:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103534 |
| 2025-08-0607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103528 |
| 2025-06-1216:18 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-085374 |
| 2025-05-0607:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063957 |
| 2025-05-0607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063954 |
| 2025-04-1716:05 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0000950170-25-055372 |
| 2025-03-1207:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-037621 |
| 2025-03-1207:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-037619 |
| 2024-11-0707:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122793 |
| 2024-11-0707:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122784 |
| 2024-10-2216:06 ET | SC 13D | Ownership report, active investor | 0001193125-24-241045 |
| 2024-10-1716:16 ET | SC 13D | Ownership report, active investor | 0000947871-24-000805 |
| 2024-10-1516:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-237580 |
| 2024-10-0706:08 ET | S-1/A | Registration statement, amended | 0001193125-24-233296 |
| 2024-09-1816:06 ET | S-1 | Registration statement | 0001193125-24-221372 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:14 ET. Listed shows no prices and gives no investment advice.